Search

1 Results found

The Veterinary33 debates veterinary-today

29 August 2022

ELIAS debuts ECI immunotherapy

Biotechnology company, ELIAS Animal Health, has shared results of a new therapy that activates T-cells to attack cancer. The company focuses on canine cancer treatment with immunotherapy

Like0

Dislike0

Page of 1 1

News of interest

Veterinary Professions Advising Center: an innovative approach to preveterinary advising for Animal Science students

Notes from the Field: Strengthening vaccine confidence through science, policy, and public engagement

German Shepherd in Clinical Trial Still in Remission Five Years After Lymphoma Diagnosis

Landmark study finds striking parallels in feline, human cancers

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top